Free Trial

Zentek (CVE:ZEN) Shares Cross Below 200 Day Moving Average - What's Next?

Zentek logo with Medical background

Key Points

  • Zentek Ltd. (CVE:ZEN) shares recently fell below their 200-day moving average, marking a significant trading low of C$1.10, while currently trading at C$1.11.
  • The company has a market capitalization of C$114.03 million, with a PE ratio of -10.47 and liquidity ratios indicating a strong current ratio of 2.06.
  • Zentek specializes in the research and development of graphene and related nanomaterials, producing products like antimicrobial coatings and diagnostic tests.
  • Looking to export and analyze Zentek data? Unlock 5 Weeks of MarketBeat All Access for Just $5. Claim Your Limited-Time Discount.

Shares of Zentek Ltd. (CVE:ZEN - Get Free Report) crossed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of C$1.63 and traded as low as C$1.10. Zentek shares last traded at C$1.11, with a volume of 43,990 shares.

Zentek Stock Down 5.4%

The firm has a market cap of C$107.87 million, a price-to-earnings ratio of -9.91 and a beta of 0.77. The firm's fifty day moving average is C$1.45 and its two-hundred day moving average is C$1.62. The company has a debt-to-equity ratio of 4.97, a current ratio of 2.06 and a quick ratio of 7.59.

Zentek Company Profile

(Get Free Report)

Zentek Ltd., together with its subsidiaries, engages in the research and development of graphene and related nanomaterials in Canada. The company develops graphene-based antimicrobial coating under the ZenGUARD brand, surgical masks, HVAC filters, personal protective equipment, rapid detection point of care diagnostics tests, and pharmaceutical products based on graphene-based compounds.

See Also

Should You Invest $1,000 in Zentek Right Now?

Before you consider Zentek, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Zentek wasn't on the list.

While Zentek currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Palantir’s Soaring Valuation—Justified or Overhyped?
3 Stocks With Explosive Upside
September Slowdown: 3 Stocks to Buy When the Pullback Comes

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines